Chuankui Li

287, Changhuai Road, Longzihu District, P.R. China
Bengbu, 233000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Silence of circPLK1 inhibits NSCLC progression by regulating the miR-1294/SLC16A9 axis.

Silence of circPLK1 inhibits NSCLC progression by regulating the miR-1294/SLC16A9 axis.

Journal: Molecular immunology

Published: July 18, 2025

Tumor-associated macrophages derived exosomal circPLK1 promotes resistance to EGFR inhibitor osimertinib in non-small cell lung cancer.

Tumor-associated macrophages derived exosomal circPLK1 promotes resistance to EGFR inhibitor osimertinib in non-small cell lung cancer.

Journal: Discover oncology

Published: November 28, 2024

TFAP2A Transcriptionally Activates CST2 to Promote the Malignant Progression of Non-Small Cell Lung Cancer.

TFAP2A Transcriptionally Activates CST2 to Promote the Malignant Progression of Non-Small Cell Lung Cancer.

Journal: Journal of biochemical and molecular toxicology

Published: September 19, 2024

Comparative outcomes of video-assisted thoracoscopic surgery versus open surgery for bronchogenic cysts in adults: a retrospective cohort study.

Comparative outcomes of video-assisted thoracoscopic surgery versus open surgery for bronchogenic cysts in adults: a retrospective cohort study.

Journal: Journal of thoracic disease

Published: April 11, 2024

Thoracoscopic Lobectomy versus Segmentectomy in the Treatment of Patients with Early-Stage Lung Cancer.

Thoracoscopic Lobectomy versus Segmentectomy in the Treatment of Patients with Early-Stage Lung Cancer.

Journal: Evidence-based complementary and alternative medicine : eCAM

Published: March 08, 2022

Upregulation of exosomal circPLK1 promotes the development of non-small cell lung cancer through the miR-1294/ high mobility group protein A1 axis.

Upregulation of exosomal circPLK1 promotes the development of non-small cell lung cancer through the miR-1294/ high mobility group protein A1 axis.

Journal: Bioengineered

Published: February 04, 2022

Knockdown of PNO1 inhibits esophageal cancer progression.

Knockdown of PNO1 inhibits esophageal cancer progression.

Journal: Oncology reports

Published: July 23, 2020

RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.

RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 07, 2018

Relationship among the expression of lymphatic vessel density, microvessel density, carcinoembryonic antigenic mRNA, KAI1, and Kiss-1, and prognosis in patients with non-small cell lung cancer

Relationship among the expression of lymphatic vessel density, microvessel density, carcinoembryonic antigenic mRNA, KAI1, and Kiss-1, and prognosis in patients with non-small cell lung cancer

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: June 12, 2012

Showing 1-9 of 9

Last Updated: 09/26/2026